OV329 — Clinical data readout
Late 2026
The Company intends to test three doses of OV329, including 5, 7 and 9 milligrams, and anticipates results near year end 2026.Source filing
OVID biotech catalysts & pipeline
OVID THERAPEUTICS INC · Data as of 2026-10-25